While this fourth-quarter purchase might seem like cause for celebration, investors would be wise to temper their expectations.

Amazon takes 5.3% stake in BETA Technologies, shares higher. Moderna drops after FDA refuses to file for mRNA-1010 influenza vaccine. Estée Lauder sues Walmart for selling counterfeits.

U.S. stocks ended higher to, led by gains in Alphabet, Amazon and other Wall Street heavyweights after the Supreme Court struck down President Donald Trump’s global tariffs.

Bill Ackman has nearly a quarter of his portfolio split between Amazon and Meta Platforms.

Amazon's Q2 results were solid and in line with my expectations, despite a steep post-earnings sell-off that I view as unjustified. Key growth drivers - cloud, advertising and 3rd party - are ...

View post: Amazon is selling a ‘versatile’ 19-piece cookware set for only $100, and it's a 'game changer in the kitchen’ However, the rollout occurs at a time of increased pressure from both within ...

Amazon's median target price of $262 per share currently implies 24% upside, making it the best trillion-dollar stock to buy now, according to Wall Street. Amazon shares have dropped 10% since its ...